Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP621938.RAqcXpi1EQfWB46BwY2Iw-BE1IXdCCmvEg7R5xompTLgo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP621938.RAqcXpi1EQfWB46BwY2Iw-BE1IXdCCmvEg7R5xompTLgo130_assertion type Assertion NP621938.RAqcXpi1EQfWB46BwY2Iw-BE1IXdCCmvEg7R5xompTLgo130_head.
- NP621938.RAqcXpi1EQfWB46BwY2Iw-BE1IXdCCmvEg7R5xompTLgo130_assertion wasGeneratedBy ECO_0000203 NP621938.RAqcXpi1EQfWB46BwY2Iw-BE1IXdCCmvEg7R5xompTLgo130_provenance.
- NP621938.RAqcXpi1EQfWB46BwY2Iw-BE1IXdCCmvEg7R5xompTLgo130_assertion wasDerivedFrom befree-20150227 NP621938.RAqcXpi1EQfWB46BwY2Iw-BE1IXdCCmvEg7R5xompTLgo130_provenance.
- NP621938.RAqcXpi1EQfWB46BwY2Iw-BE1IXdCCmvEg7R5xompTLgo130_assertion SIO_000772 15548710 NP621938.RAqcXpi1EQfWB46BwY2Iw-BE1IXdCCmvEg7R5xompTLgo130_provenance.
- NP621938.RAqcXpi1EQfWB46BwY2Iw-BE1IXdCCmvEg7R5xompTLgo130_assertion evidence source_evidence_literature NP621938.RAqcXpi1EQfWB46BwY2Iw-BE1IXdCCmvEg7R5xompTLgo130_provenance.
- NP621938.RAqcXpi1EQfWB46BwY2Iw-BE1IXdCCmvEg7R5xompTLgo130_assertion description "[Thus, inhibition of PI3K activity with concomitant administration of chemotoxic compounds may prove beneficial in preventing the development of drug resistance in patients with hormone-refractory prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621938.RAqcXpi1EQfWB46BwY2Iw-BE1IXdCCmvEg7R5xompTLgo130_provenance.